Franklin Berger

(Mr. Franklin Berger CFA)

Currently holds positions in ESSA Pharma Inc, Five Prime Therapeutics Inc, Atreca Inc, Proteostasis Therapeutics Inc and Kezar Life Sciences Inc

Positions

Position Company Period
Director ESSA Pharma Inc Jan. 1, 2016 -
Independent Director Five Prime Therapeutics Inc Sept. 1, 2010 -
Independent Director Atreca Inc Oct. 1, 2014 -
Independent Director Proteostasis Therapeutics Inc Feb. 1, 2016 -
Independent Director Kezar Life Sciences Inc Nov. 1, 2016 -
Independent Director Immune Design Corp March 1, 2014 - April 2, 2019
Independent Director ESSA Pharma Inc March 5, 2015 - Jan. 1, 2016
Independent Director Seagen Inc June 1, 2004 - May 16, 2014
Director Lineage Cell Therapeutics Inc May 13, 2013 - March 21, 2014
Director Asterias Biotherapeutics Inc June 1, 2013 - March 21, 2014
Franklin Berger's trades of Atea Pharmaceuticals Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-12-12 2024-12-10
S Sale
359,606 -44.3%
2.85
USD 1,023,475 		359,606 -44.3% 2.85 USD 1,023,475
2023-11-22 2023-11-21
B Purchase
23,259 +3.1%
5.73
USD 133,274 		23,259 +3.1% 5.73 USD 133,274
2023-11-16 2023-11-03
B Purchase
16,471 +2.2%
5.99
USD 98,661 		16,471 +2.2% 5.99 USD 98,661
2023-11-16 2023-11-02
B Purchase
60,000 +8.8%
5.35
USD 321,000 		60,000 +8.8% 5.35 USD 321,000
2023-01-05 2022-12-21
S Sale
34,334 -4.8%
2.42
USD 83,088 		34,334 -4.8% 2.42 USD 83,088
2023-01-05 2022-12-21
S Sale
37,889 -5.0%
2.41
USD 91,312 		37,889 -5.0% 2.41 USD 91,312
2023-01-05 2022-12-20
S Sale
43,617 -5.5%
2.53
USD 110,351 		43,617 -5.5% 2.53 USD 110,351
2023-01-05 2022-12-16
S Sale
50,000 -5.9%
2.67
USD 133,500 		50,000 -5.9% 2.67 USD 133,500
2023-01-05 2022-12-15
S Sale
50,000 -5.6%
2.86
USD 143,000 		50,000 -5.6% 2.86 USD 143,000
2023-01-05 2022-12-15
S Sale
32,000 -3.4%
2.90
USD 92,800 		32,000 -3.4% 2.90 USD 92,800
2023-01-05 2022-12-14
S Sale
25,000 -2.6%
3.00
USD 75,000 		25,000 -2.6% 3.00 USD 75,000
2022-11-23 2022-11-22
B Purchase
77,000 +8.3%
8.27
USD 636,790 		77,000 +8.3% 8.27 USD 636,790
2022-11-23 2022-11-21
B Purchase
45,000 +5.1%
7.80
USD 351,000 		45,000 +5.1% 7.80 USD 351,000
2022-11-15 2022-11-14
S Sale
16,166 -2.0%
5.16
USD 83,352 		16,166 -2.0% 5.16 USD 83,352
2022-11-15 2022-11-11
S Sale
25,500 -3.1%
5.15
USD 131,333 		25,500 -3.1% 5.15 USD 131,333
2022-11-14 2022-11-08
B Purchase
42,881 +5.1%
5.83
USD 249,996 		42,881 +5.1% 5.83 USD 249,996
2022-03-22 2022-03-21
B Purchase
20,000 +2.3%
14.77
USD 295,400 		20,000 +2.3% 14.77 USD 295,400
2022-03-22 2022-03-18
B Purchase
45,000 +5.4%
17.00
USD 765,000 		45,000 +5.4% 17.00 USD 765,000
2022-03-22 2022-03-18
B Purchase
15,000 +1.9%
15.96
USD 239,400 		15,000 +1.9% 15.96 USD 239,400
2021-04-27 2021-04-23
B Purchase
5,000 +4.2%
15.78
USD 78,900 		5,000 +4.2% 15.78 USD 78,900
2021-04-27 2021-04-23
B Purchase
120,000 +inf%
17.00
USD 2,040,000 		120,000 +inf% 17.00 USD 2,040,000
2021-03-04 2021-02-22
B Purchase
57,000 +6.3%
27.00
USD 1,539,000 		57,000 +6.3% 27.00 USD 1,539,000
2020-11-03 2020-11-03
B Purchase
41,666 +5.4%
24.00
USD 999,984 		41,666 +5.4% 24.00 USD 999,984
2020-06-11 2020-06-11
B Purchase
100,000 +14.6%
5.50
USD 550,000 		100,000 +14.6% 5.50 USD 550,000
2020-02-05 2020-02-04
B Purchase
120,846 +21.5%
2.60
USD 314,200 		120,846 +21.5% 2.60 USD 314,200
2013-08-22 2013-08-20
B Purchase
500 +inf%
3.71
USD 1,855 		500 +inf% 3.71 USD 1,855
// ... existing code ... // ... rest of the file ...